MR-Linac radiation for advanced colon cancer
Part of Cancer clinical trials.
This trial tests a new radiation machine called MR-Linac for people with advanced colon cancer that cannot be removed by surgery. The goal is to see if it is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You can lie still for 1 to 1.5 hours
- Your cancer has not spread to distant organs (stage M0)
- You have not had previous treatment for this cancer
- Your tumor is not a type called dMMR or MSI-H
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation therapy that uses real-time MRI imaging to adjust the radiation precisely to your tumor. It is designed to improve the accuracy of treatment for locally advanced rectal cancer, potentially reducing damage to nearby healthy tissue.
This trial tests a new type of radiotherapy that uses MRI scans to guide the radiation beam more precisely. It aims to treat tumors while reducing damage to healthy tissue.
This study follows what happens when radiation treatment is guided using an MR-Linac (a special machine that combines MRI imaging with radiation). It may help improve how radiation therapy is planned and assessed, especially for people who can safely have MRI scans.
This trial tests a new way of giving radiation therapy for rectal cancer, using MRI scans to aim the radiation more precisely. It's for people who need chemotherapy and radiation before surgery, and it aims to make treatment more effective while reducing side effects.
This trial checks whether it’s practical and safe to deliver radiation treatment using real-time MRI guidance, with the process supported online. It may help patients whose doctors recommend radiation by testing a modern way to plan and deliver treatment more precisely.
This trial tests a new way to give high-dose radiation to rectal cancer tumors while avoiding the bladder and bowels. The goal is to cure the cancer without removing the rectum, so you may keep normal bowel function.
Hear when a new Safety and Efficacy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.